Skip to Main Content

Author Details

Jin-Ku Lee
Seoul National University, College of Medicine
2010
28
18
PMIDPaper TitleJournal TitlePublished Year
36924663High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.Biomaterials2023
37788099The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling.JCI Insight2023
36972629Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5.Neoplasia2023
36116121Unraveling the Transcriptomic Signatures of Homologous Recombination Deficiency in Ovarian Cancers.Adv Biol (Weinh)2022
32120790Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening.Cancers (Basel)2020
33149237Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target.Exp Mol Med2020
30898893PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma.J Exp Med2019
31811117Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.Exp Mol Med2019
29939324Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.Neuro Oncol2019
30262818Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.Nat Genet2018
28263318Spatiotemporal genomic architecture informs precision oncology in glioblastoma.Nat Genet2017
26032834USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance.Neuro Oncol2016
26641068WNT signaling in glioblastoma and therapeutic opportunities.Lab Invest2016
27270107Clonal evolution of glioblastoma under therapy.Nat Genet2016
26893731Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges.Oncol Lett2016
26023737In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma.Oncotarget2015
243334208-Oxo-2'-deoxyguanosine ameliorates features of metabolic syndrome in obese mice.Biochem Biophys Res Commun2014
25364264Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling.Onco Targets Ther2014
22835616Simvastatin suppresses RANTES-mediated neutrophilia in polyinosinic-polycytidylic acid-induced pneumonia.Eur Respir J2013
23628332Anti-adipogenic activity of compounds isolated from Idesia polycarpa on 3T3-L1 cells.Bioorg Med Chem Lett2013
23649461Relative antioxidant activities of quercetin and its structurally related substances and their effects on NF-κB/CRE/AP-1 signaling in murine macrophages.Mol Cells2013
23702480BST-2 is a potential activator of invasion and migration in tamoxifen-resistant breast cancer cells.Biochem Biophys Res Commun2013
23746113Signal transducer and activator of transcription 3 (Stat3) contributes to T-cell homeostasis by regulating pro-survival Bcl-2 family genes.Immunology2013
234662368-Oxo-2'-deoxyguanosine ameliorates UVB-induced skin damage in hairless mice by scavenging reactive oxygen species and inhibiting MMP expression.J Dermatol Sci2013
23074171STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells.Mol Cancer Res2013
22962574Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis.PLoS One2012
211149818-oxo-2'-deoxyguanosine suppresses allergy-induced lung tissue remodeling in mice.Eur J Pharmacol2011
20332458CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.Anticancer Res2010
  • 1 - 28 of 28

Recommended Authors

Vikas Patil
Princess Margaret Hospital
Career Start Year 2013
Number of shared co-authors 0
Gen Li
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 0
Taher Abbasi
Cellworks Group Inc.
Career Start Year 2011
Number of shared co-authors 0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Huiyuan Zhang
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Qianghu Wang
Center for Global Health, School of Public Health, Nanjing Medical University
Career Start Year 2009
Number of shared co-authors 15
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 4
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Anita B Hjelmeland
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 1
Jinbo Yang
School of Medicine and Pharmacy, Ocean University of China
Career Start Year 2003
Number of shared co-authors 1
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 7
Aidong Zhou
Southern Medical University
Career Start Year 2002
Number of shared co-authors 1
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Agnieszka Bronisz
Mossakowski Medical Research Institute, Polish Academy of Sciences
Career Start Year 1999
Number of shared co-authors 1
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 11
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 3
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 4
Paul S Mischel
Stanford University
Career Start Year 1994
Number of shared co-authors 1
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 9
Xiao-Nan Li
Northwestern University
Career Start Year 1992
Number of shared co-authors 2
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 4

Collaborators

Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 14
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Co-authored papers 11
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 9
Jason K Sa
Korea University, College of Medicine
Co-authored papers 7
Donggeon Kim
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 7
Hyun Ju Kang
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers 7
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers 6
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 5
Raul Rabadan
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers 5
Hyemi Shin
Research Institute for Future Medicine, Samsung Medical Center
Co-authored papers 5
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 5
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 5
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers 5
Zhaoqi Liu
University of Chinese Academy of Sciences
Co-authored papers 5
Sung Heon Kim
Sungkyunkwan University
Co-authored papers 4
Yeup Yoon
Sungkyunkwan University
Co-authored papers 4
Jung Won Choi
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 3
In-Hee Lee
Children's Hospital Boston
Co-authored papers 3
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 3
Jiguang Wang
The Hong Kong University of Science and Technology
Co-authored papers 3
Jeong-Woo Oh
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 3
Daniel I S Rosenbloom
Merck & Co. Inc.
Co-authored papers 3
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 3
Misuk Kim
Inha University
Co-authored papers 3
In-Hee Lee
Co-authored papers 3
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 3
Erik Ladewig
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Oliver Elliott
Columbia University
Co-authored papers 2
Seung Won Choi
Samsung Medical Center, Sungkyunkwan University
Co-authored papers 2
Harim Koo
Korea University College of Medicine
Co-authored papers 2
Release 1.2